跳至主要内容
临床试验/NCT02239913
NCT02239913已完成1 期

Topiramate-Phentermine Combinations for Cocaine Dependence

University of Kentucky1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
38
试验地点
1
主要终点
Reinforcing Effects

研究概览

简要总结

This study will determine the influence of topiramate (Topamax®) and phentermine (Adipex®), alone and in combination, on the reinforcing, subjective and physiological effects of cocaine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Recent cocaine use by the intranasal or intravenous route

排除标准

  • Abnormal screening outcome (e.g., ECG, blood chemistry result) that study physicians deem clinically significant
  • Current or past histories of substance abuse or dependence that are deemed by the study physicians to interfere with study completion
  • History of serious physical disease, current physical disease, impaired cardiovascular functioning, chronic obstructive pulmonary disease, history of seizure or current or past histories of serious psychiatric disorder that in the opinion of the study physician would interfere with study participation will be excluded from participation
  • Females not currently using effective birth control
  • Contraindications to cocaine, topiramate or phentermine

研究组 & 干预措施

Placebo

Placebo Comparator

Subjects will be maintained on oral placebo. Subjects will be maintained on placebo and phentermine during placebo maintenance. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Cocaine (Drug)

Placebo

Placebo Comparator

Subjects will be maintained on oral placebo. Subjects will be maintained on placebo and phentermine during placebo maintenance. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Placebo (Drug)

Placebo

Placebo Comparator

Subjects will be maintained on oral placebo. Subjects will be maintained on placebo and phentermine during placebo maintenance. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Phentermine (Drug)

Topiramate Dose 1

Experimental

Subjects will be maintained on the low topiramate dose. Subjects will be maintained on placebo and phentermine during maintenance on the low dose of topiramate. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Cocaine (Drug)

Topiramate Dose 1

Experimental

Subjects will be maintained on the low topiramate dose. Subjects will be maintained on placebo and phentermine during maintenance on the low dose of topiramate. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Placebo (Drug)

Topiramate Dose 1

Experimental

Subjects will be maintained on the low topiramate dose. Subjects will be maintained on placebo and phentermine during maintenance on the low dose of topiramate. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Phentermine (Drug)

Topiramate Dose 1

Experimental

Subjects will be maintained on the low topiramate dose. Subjects will be maintained on placebo and phentermine during maintenance on the low dose of topiramate. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Topiramate (Drug)

Topiramate Dose 2

Experimental

Subjects will be maintained on the high topiramate dose. Subjects will be maintained on placebo and phentermine during maintenance on the high dose of topiramate. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Cocaine (Drug)

Topiramate Dose 2

Experimental

Subjects will be maintained on the high topiramate dose. Subjects will be maintained on placebo and phentermine during maintenance on the high dose of topiramate. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Placebo (Drug)

Topiramate Dose 2

Experimental

Subjects will be maintained on the high topiramate dose. Subjects will be maintained on placebo and phentermine during maintenance on the high dose of topiramate. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Phentermine (Drug)

Topiramate Dose 2

Experimental

Subjects will be maintained on the high topiramate dose. Subjects will be maintained on placebo and phentermine during maintenance on the high dose of topiramate. Cocaine will be administered acutely during placebo maintenance. Placebo will be administered acutely during placebo maintenance.

干预措施: Topiramate (Drug)

结局指标

主要结局

Reinforcing Effects

时间窗: Nine times over approximately five weeks inpatient admission.

The reinforcing effects of cocaine will be determined using a self-administration procedure in which subjects choose to take previously sampled doses.

次要结局

  • Subjective effects(Nine times over approximately five weeks inpatient admission.)
  • Side effects(Daily over approximately five weeks of inpatient admission)
  • Physiological Effects(Daily over approximately five week inpatient admissions)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Craig Rush

Professor

University of Kentucky

研究点 (1)

Loading locations...

相似试验